![]() |
CONCLUSIONS Compared with simvastatin, atorvastatin reduced hsCRP and its variability in type 2 diabetic patients. This enhanced anti-inflammatory effect. Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial). Jones PH, Davidson MH. Safety and efficacy of combination versus atorvastatin. mg vs -50.8% for atorvastatin 40 mg; p ||||||
Home | Products | Services | Click Print | Contact Us | What's New | ||||||
|